Lucence (ctDNA + ctRNA test, improves detection of fusions)

A combined ctDNA and ctRNA liquid biopsy that improves detection of fusions to inform treatment.

Vetted listing
Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why Lucence exists

Lucence provides a liquid biopsy test that analyzes both ctDNA and ctRNA, improving detection of fusions. It gathers biomarkers from blood and other bodily fluids that can guide treatment and monitor disease progression, including minimum residual disease monitoring and early detection. Patients get a fuller biomarker picture from a fluid-based test.

CAP accreditedCLIA certified

Prefer the source? Lucence (ctDNA + ctRNA test, improves detection of fusions)'s own site has more.

Get started with Lucence (ctDNA + ctRNA test, improves detection of fusions)

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Lucence (ctDNA + ctRNA test, improves detection of fusions) handles billing.

We don't have confirmed insurance details for Lucence (ctDNA + ctRNA test, improves detection of fusions) yet. Start a coverage check with your plan, or contact the provider directly.

Understand this before you decide

Ask about this service

Answers grounded in Lucence's details here. Educational only; your oncologist directs treatment.

Powered by Navis on opencancer.ai

Also consider

Other providers in similar categories.

Get personalized guidance for your case

This page is general information. Upload your records for analysis specific to YOUR diagnosis.